Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations.
暂无分享，去创建一个
D. Steinemann | L. Bullinger | H. Pahl | M. Sanders | P. Valk | B. Schlegelberger | E. Raffoux | A. Zeilemaker | K. Aumann | Wei Wang | B. Cassinat | A. A. Hinai | J. Jutzi | S. Kaiser | T. Basu | Jenny Ostendorp | Christoph Koellerer | Maximilian Pellmann | Sarolta Bojtine Kovacs